Teladoc Health has partnered with Eli Lilly’s LillyDirect and pharmacy provider GiftHealth to expand access to Zepbound, a GLP-1 drug prescribed for weight loss. The partnership allows Teladoc ...

Partly cloudy with a high of 70 °F (21.1 °C). Winds from S to SSW at 18 to 22 mph (29 to 35.4 kph). Night - Cloudy with a 55% chance of precipitation. Winds from SSW to SW at 9 to 19 mph (14.5 ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

Teladoc Health recently announced a pharmacy integration agreement with Eli Lilly, which aims to enhance access to GLP-1 medications for obesity as part of their Comprehensive Weight Care Program.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

Novo Nordisk is cutting the price of its weight-loss drug Wegovy to $499 per month for cash-paying customers who buy through its NovoCare Pharmacy ... by competitor Eli Lilly for its weight ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 25 trades. If we consider the specifics of ...

Eli Lilly has launched new 7.5 mg and 10 mg single ... by offering these doses exclusively through LillyDirect Self Pay Pharmacy Solutions, thereby eliminating third-party supply chain costs ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on ...